ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301)

PHASE3CompletedINTERVENTIONAL
Enrollment

555

Participants

Timeline

Start Date

September 30, 2005

Conditions
Alzheimer's Disease
Interventions
DRUG

VP4896

Trial Locations (59)

12205

Upstate Clinical Research, LLC, Albany

19046

Clinical Trial Center, LLC., Jenkintown

19401

Pearl Clinical Research, Inc., Norristown

22304

Innovative Clinical Research Center, Alexandria

27103

Piedmont Medical Research Associates, Winston-Salem

27607

Raleigh Neurology Associates, P.A., Raleigh

28655

Medark Clinical Trials, Morgantown

29651

Radiant Research - Greer, Greer

33016

Berma Research Group, Hialeah

33324

Neurology Clinical Research, LLC, Plantation

33407

Palm Beach Neurological Group, West Palm Beach

33409

Quantum Laboratories, West Palm Beach

33445

Brain Matters Research, Delray Beach

33609

Meridien Research, Tampa

33709

Meridien Research, St. Petersburg

34243

Roskamp Institute, Sarasota

34613

Meridien Research, Brookville

43210

Ohio State University Medical Center, Columbus

43623

Neurology Center of Ohio, Toledo

48073

Pivotal Research Centers, Royal Oak

68198

University of Nebraska Medical Center, Omaha

71104

Booker, J. Gary, MD, APMC, Shreveport

73103

IPS Research Company, Oklahoma City

76309

Grayline Clinical Drug Trials, Wichita Falls

77030

University of Texas Health Science Center at Houston, Houston

78229

Bexar Diagnostic Medicine Associates, San Antonio

80212

Radiant Research, Denver

80218

Colorado Neurology & Headache Center, Denver

85381

Pivotal Research Centers, Peoria

85741

NeuroSpecialists, PLLC, Tucson

87102

Albuquerque Neuroscience Inc., Albuquerque

90035

David Trader, Los Angeles

90404

Neurological Research Institute, Santa Monica

90505

Torrance Clinical Research, Torrance

90720

Pharmacology Research Institute, Los Alamitos

91324

Pharmacology Research Institute, Northridge

91950

Synergy Clinical Research, National City

92056

North County Neurology Assoc., Oceanside

Pharmacology Research Institute, Riverside

92103

Pacific Research Network, San Diego

92354

Anderson Clinical Research, Loma Linda

92660

Pharmacology Research Institute, Newport Beach

93720

Margolin Brain Institute, Fresno

94109

San Francisco Clinical Research Center, San Francisco

94549

Bay Area Research Institute, Lafayette

96817

Kuakani Medical Center, Honolulu

97401

Pharmaceutical Research-Oregon, Inc., Eugene

06820

Comprehensive Neuroscience, Inc., Darien

06518

Geriatric and Adult Psychiatry, Hamden

02131

ICPS Group, Boston

08822

Hunterdon Medical Center, Flemington

02914

Memory Research Institute, East Providence

02906

Butler Hospital, Providence

02916

Norman Gordon, MD, Providence

05201

Southwestern Vermont Medical Center, Bennington

V2ASC8

The Medical Arts Health Research Group, Penticton

B3H2E1

Queen Elizabeth II Health Sciences Centre, Halifax

M2J5A3

Toronto Memory Program (Neurology Research Inc.), Toronto

J1G2E8

Novabyss Inc., Sherbrooke

All Listed Sponsors
lead

Voyager Pharmaceutical Corporation

INDUSTRY

NCT00231946 - ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) | Biotech Hunter | Biotech Hunter